Cue Health, Inc.

( )
HLTH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 0.21%545.951.0%$723.18m
DHRDanaher Corp. 1.25%260.150.7%$689.94m
MDTMedtronic Plc -0.31%90.190.6%$689.91m
ABTAbbott Laboratories -0.02%109.430.8%$608.35m
ISRGIntuitive Surgical, Inc. 0.63%210.990.8%$457.23m
BSXBoston Scientific Corp. 0.32%38.141.0%$339.98m
ALGNAlign Technology, Inc. 0.00%258.756.4%$321.15m
BDXBecton, Dickinson & Co. -0.05%250.801.0%$275.10m
EWEdwards Lifesciences Corp. 0.30%97.270.4%$268.56m
SYKStryker Corp. 0.61%205.991.3%$266.48m
IDXXIDEXX Laboratories, Inc. 0.00%361.483.8%$242.08m
AAgilent Technologies, Inc. -0.20%121.051.7%$225.19m
BAXBaxter International, Inc. 0.00%66.781.8%$207.19m
SWAVShockwave Medical, Inc. 0.00%197.690.0%$175.43m
DXCMDexCom, Inc. 0.00%77.671.9%$172.64m

Company Profile

Cue Health, Inc. is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. It enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. The firms first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. The company was founded by Ayub Khattak and Clint Sever in 2010 and is headquartered in San Diego, CA.